ODI — Odi Pharma AB (publ) Balance Sheet
0.000.00%
- SEK27.16m
- SEK25.67m
- SEK3.11m
Annual balance sheet for Odi Pharma AB (publ), fiscal year end - June 30th, SEK millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 14.6 | 7.37 | 6.49 | 2.64 | 1.48 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.932 | 1.09 | 0.813 | 8.98 | 3.89 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 16.9 | 10.5 | 8.18 | 12.2 | 5.75 |
| Net Property, Plant And Equipment | 0.012 | 0.012 | 0.009 | 0.006 | 0.004 |
| Other Long Term Assets | |||||
| Total Assets | 16.9 | 10.5 | 8.19 | 12.2 | 5.76 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.582 | 1.24 | 5.61 | 10.2 | 4.94 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.582 | 1.24 | 5.61 | 10.2 | 4.94 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 16.3 | 9.26 | 2.57 | 2 | 0.814 |
| Total Liabilities & Shareholders' Equity | 16.9 | 10.5 | 8.19 | 12.2 | 5.76 |
| Total Common Shares Outstanding |